Ckd Bio Cash Flow Quality Index
Ckd Bio cash flow quality index. Ckd Bio (063160) has a Cash Flow Quality Index of -5.50x as of March 2025. Operating cash flow of ₩-4.95 Billion is below net income of ₩900.16 Million, suggesting accrual-heavy earnings not yet converted to cash. See Ckd Bio leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Ckd Bio (2008–2024)
Cash flow quality index of Ckd Bio from 2008 to 2024. Historical Cash Flow Quality Index for Ckd Bio across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Ckd Bio debt service capacity to assess how comfortably operating cash covers total debt obligations.
Ckd Bio Cash Flow Quality Index by Year (2008–2024)
Ckd Bio cash flow quality index by year from 2008 to 2024. Year-by-year earnings quality comparison for Ckd Bio. For the full cash flow conversion analysis, see Ckd Bio cash conversion from operations.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.61x | ₩14.03 Billion | ₩8.70 Billion | ▲ +107.5% |
| 2020 | 0.78x | ₩4.82 Billion | ₩6.21 Billion | ▼ -43.9% |
| 2019 | 1.39x | ₩16.99 Billion | ₩12.26 Billion | ▼ -29.1% |
| 2018 | 1.95x | ₩15.54 Billion | ₩7.96 Billion | ▼ -23.4% |
| 2017 | 2.55x | ₩20.45 Billion | ₩8.02 Billion | ▲ +55.2% |
| 2016 | 1.64x | ₩15.50 Billion | ₩9.43 Billion | ▼ -23.8% |
| 2015 | 2.16x | ₩14.34 Billion | ₩6.65 Billion | ▼ -67.3% |
| 2013 | 6.59x | ₩10.92 Billion | ₩1.66 Billion | ▲ +104.4% |
| 2012 | 3.22x | ₩22.90 Billion | ₩7.10 Billion | ▲ +171.7% |
| 2011 | 1.19x | ₩12.96 Billion | ₩10.92 Billion | ▼ -28.6% |
| 2010 | 1.66x | ₩23.89 Billion | ₩14.38 Billion | ▲ +1.2% |
| 2009 | 1.64x | ₩26.57 Billion | ₩16.18 Billion | ▲ +34.2% |
| 2008 | 1.22x | ₩10.69 Billion | ₩8.74 Billion | — |